Bronkoskopisk lungevolumenreduktion er et behandlingstilbud til patienter med svært heterogent emfysem

Michael Perch; Ingrid L Titlestad; Beata A Rychwicha-Kielek; Elisabeth Bendstrup; Martin Iversen; Mette Siemsen; Ole D Jørgensen; Poul Erik Haahr

Bronkoskopisk lungevolumenreduktion er et behandlingstilbud til patienter med svært heterogent emfysem

Michael Perch, Ingrid L Titlestad, Beata A Rychwicha-Kielek, Elisabeth Bendstrup, Martin Iversen, Mette Siemsen, Ole D Jørgensen, Poul Erik Haahr

Institut for Klinisk Medicin

Abstract

Introduction of bronchoscopic lung volume reduction as a treatment for severe emphysema has been defined as an area of development by The Danish Health and Medicines Authority. We here present the rationale for treatment, in- and exclusion criteria, and ultimately the organization for assessment, treatment and follow-up in Denmark. The treatment aim is to lower dyspnoea. There is a national protocol for patient selection according to in- and exclusion criteria. Different commercial devices are available, but endobronchial valves have been the devices mostly applied. A national database has been established to evaluate cost-effectiveness.

Bidragets oversatte titel	Bronchoscopic lung volume reduction is a treatment offered to patients with severe heterogenous emphysema.
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Laeger
Vol/bind	176
Udgave nummer	29
Sider (fra-til)	2-6
Antal sider	5
ISSN	0041-5782
Status	Udgivet - 14 jul. 2014

Citationsformater

@article{b8e60372b3fc4135ad9f6d682e1b7189,

title = "Bronkoskopisk lungevolumenreduktion er et behandlingstilbud til patienter med sv{\ae}rt heterogent emfysem",

abstract = "Introduction of bronchoscopic lung volume reduction as a treatment for severe emphysema has been defined as an area of development by The Danish Health and Medicines Authority. We here present the rationale for treatment, in- and exclusion criteria, and ultimately the organization for assessment, treatment and follow-up in Denmark. The treatment aim is to lower dyspnoea. There is a national protocol for patient selection according to in- and exclusion criteria. Different commercial devices are available, but endobronchial valves have been the devices mostly applied. A national database has been established to evaluate cost-effectiveness.",

author = "Michael Perch and Titlestad, {Ingrid L} and Rychwicha-Kielek, {Beata A} and Elisabeth Bendstrup and Martin Iversen and Mette Siemsen and J{\o}rgensen, {Ole D} and Haahr, {Poul Erik}",

year = "2014",

month = jul,

day = "14",

language = "Dansk",

volume = "176",

pages = "2--6",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "29",

}

TY - JOUR

T1 - Bronkoskopisk lungevolumenreduktion er et behandlingstilbud til patienter med svært heterogent emfysem

AU - Perch, Michael

AU - Titlestad, Ingrid L

AU - Rychwicha-Kielek, Beata A

AU - Bendstrup, Elisabeth

AU - Iversen, Martin

AU - Siemsen, Mette

AU - Jørgensen, Ole D

AU - Haahr, Poul Erik

PY - 2014/7/14

Y1 - 2014/7/14

N2 - Introduction of bronchoscopic lung volume reduction as a treatment for severe emphysema has been defined as an area of development by The Danish Health and Medicines Authority. We here present the rationale for treatment, in- and exclusion criteria, and ultimately the organization for assessment, treatment and follow-up in Denmark. The treatment aim is to lower dyspnoea. There is a national protocol for patient selection according to in- and exclusion criteria. Different commercial devices are available, but endobronchial valves have been the devices mostly applied. A national database has been established to evaluate cost-effectiveness.

AB - Introduction of bronchoscopic lung volume reduction as a treatment for severe emphysema has been defined as an area of development by The Danish Health and Medicines Authority. We here present the rationale for treatment, in- and exclusion criteria, and ultimately the organization for assessment, treatment and follow-up in Denmark. The treatment aim is to lower dyspnoea. There is a national protocol for patient selection according to in- and exclusion criteria. Different commercial devices are available, but endobronchial valves have been the devices mostly applied. A national database has been established to evaluate cost-effectiveness.

M3 - Tidsskriftartikel

C2 - 25292200

SN - 0041-5782

VL - 176

SP - 2

EP - 6

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 29

ER -

Bronkoskopisk lungevolumenreduktion er et behandlingstilbud til patienter med svært heterogent emfysem

Abstract

Fingeraftryk

Citationsformater